logo
Plus   Neg
Share
Email

Lilly Reports Positive Results From Taltz 5-yr Study - Quick Facts

Eli Lilly and Company (LLY) said the results from a five-year Phase 3 study for Taltz (ixekizumab) demonstrated that patients with moderate- to severe plaque psoriasis taking Taltz can achieve sustained skin clearance over the five-year treatment period. No unexpected safety outcomes were reported, the company said.

Later in the year, Eli Lilly plans to announce the results from IXORA-R, a clinical trial designed to evaluate superiority between Taltz and Tremfya (guselkumab) in adult patients with moderate- to severe plaque psoriasis.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A new survey by the National Restaurant Association or NRA has painted a grim picture regarding the outlook for the U.S. restaurant industry. According to the NRA's Restaurant Industry Tracking survey for May 2020, most restaurant operators in the U.S. said they do not expect their business to return to normal during the next several months. Tyson Foods, Inc. announced that its 815 workers were found to be coronavirus or Covid-19 positive at the facility-wide testing in two Iowa plants in Council Bluffs and Storm Lake. Meanehile, Storm Lake, Iowa pork facility will resume limited production on Wednesday following a temporary halt for additional deep cleaning and sanitizing. Swedish fashion retailer Hennes & Mauritz AB or H&M has temporarily shuttered 95 of its stores in various regions across the U.S. following violence and looting amid the unrest related to the death of George Floyd. Street protests, some peaceful and some violent, erupted across the nation after Floyd was mercilessly killed by Minnesota police.
Follow RTT